Artículos de revistas sobre el tema "In silico drug repurposing pipeline development"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "In silico drug repurposing pipeline development".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Tinivella, Annachiara, Luca Pinzi, Guido Gambacorta, Ian Baxendale y Giulio Rastelli. "Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies". F1000Research 11 (23 de febrero de 2022): 217. http://dx.doi.org/10.12688/f1000research.109017.1.
Texto completoTinivella, Annachiara, Luca Pinzi, Guido Gambacorta, Ian Baxendale y Giulio Rastelli. "Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies". F1000Research 11 (23 de marzo de 2022): 217. http://dx.doi.org/10.12688/f1000research.109017.2.
Texto completoFerraz, Witor Ribeiro, Renan Augusto Gomes, Andre Luis S Novaes y Gustavo Henrique Goulart Trossini. "Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study". Future Medicinal Chemistry 12, n.º 20 (octubre de 2020): 1815–28. http://dx.doi.org/10.4155/fmc-2020-0165.
Texto completoPérez-Moraga, Raul, Jaume Forés-Martos, Beatriz Suay-García, Jean-Louis Duval, Antonio Falcó y Joan Climent. "A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework". Pharmaceutics 13, n.º 4 (2 de abril de 2021): 488. http://dx.doi.org/10.3390/pharmaceutics13040488.
Texto completoNgwewondo, Adela, Ivan Scandale y Sabine Specht. "Onchocerciasis drug development: from preclinical models to humans". Parasitology Research 120, n.º 12 (13 de octubre de 2021): 3939–64. http://dx.doi.org/10.1007/s00436-021-07307-4.
Texto completoKhan, Saba, Jaya Agnihotri, Sunanda Patil y Nikhat Khan. "Drug repurposing: A futuristic approach in drug discovery". Journal of Pharmaceutical and Biological Sciences 11, n.º 1 (15 de julio de 2023): 66–69. http://dx.doi.org/10.18231/j.jpbs.2023.011.
Texto completoChipofya, Mapopa, Hilal Tayara y Kil To Chong. "Drug Therapeutic-Use Class Prediction and Repurposing Using Graph Convolutional Networks". Pharmaceutics 13, n.º 11 (10 de noviembre de 2021): 1906. http://dx.doi.org/10.3390/pharmaceutics13111906.
Texto completoKonreddy, Ananda Kumar, Grandhe Usha Rani, Kyeong Lee y Yongseok Choi. "Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics". Current Medicinal Chemistry 26, n.º 28 (25 de octubre de 2019): 5363–88. http://dx.doi.org/10.2174/0929867325666180706101404.
Texto completoShevtsov, Andrey, Mikhail Raevskiy, Alexey Stupnikov y Yulia Medvedeva. "In Silico Drug Repurposing in Multiple Sclerosis Using scRNA-Seq Data". International Journal of Molecular Sciences 24, n.º 2 (4 de enero de 2023): 985. http://dx.doi.org/10.3390/ijms24020985.
Texto completoRamamoorthi, Roopa, Katy M. Graef y Jennifer Dent. "Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline". Future Medicinal Chemistry 7, n.º 6 (abril de 2015): 727–35. http://dx.doi.org/10.4155/fmc.15.26.
Texto completoFarghali, H., N. Kutinová Canová y M. Arora. "The potential applications of artificial intelligence in drug discovery and development". Physiological Research, S4 (30 de diciembre de 2021): S715—S722. http://dx.doi.org/10.33549//physiolres.934765.
Texto completoMiller, Mark Stevn, Brian Cholewa, John Clifford, Vignesh Gunasekharan, Altaf Mohammed, Shanker Gupta, Robert Shoemaker y Shizuko Sei. "Abstract IA007: PREVENT agent development pipeline". Cancer Prevention Research 15, n.º 12_Supplement_2 (1 de diciembre de 2022): IA007. http://dx.doi.org/10.1158/1940-6215.tacpad22-ia007.
Texto completoVerma, Vikrant. "In Silico Development of Anticancer Drugs". Journal of Clinical Research and Analytical Reviews 1, n.º 1 (5 de marzo de 2022): 1–5. http://dx.doi.org/10.56391/jcrar.2022.1019.
Texto completoEntonu, Moses Edache, Mbateudi Danjuma IKA, Ekpa Emmanuel, Clifford Liki Barnabas, Daniel Danladi Gaiya y Stella Kuyet UDU. "Drug repurposing: Recent advancements, challenges, and future therapeutics for cancer treatment". Journal of Bacteriology & Mycology: Open Access 10, n.º 2 (2022): 26–30. http://dx.doi.org/10.15406/jbmoa.2022.10.00322.
Texto completoLloyd, Katie, Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, Francois Bergey, Lorna Morris, Madeleine Kittner et al. "Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease". Disease Models & Mechanisms 13, n.º 11 (21 de septiembre de 2020): dmm044040. http://dx.doi.org/10.1242/dmm.044040.
Texto completoMiroshnichenko, I. I., E. A. Valdman y I. I. Kuz'min. "Old Drugs, New Indications (Review)". Drug development & registration 12, n.º 1 (28 de febrero de 2023): 182–90. http://dx.doi.org/10.33380/2305-2066-2023-12-1-182-190.
Texto completoBeck, Samuel, Jun-Yeong Lee y Jarod Rollins. "In silico identification of anti-aging pharmaceutics from community knowledge". Innovation in Aging 5, Supplement_1 (1 de diciembre de 2021): 672. http://dx.doi.org/10.1093/geroni/igab046.2533.
Texto completoFrancisco, Amanda F., Shiromani Jayawardhana, Francisco Olmo, Michael D. Lewis, Shane R. Wilkinson, Martin C. Taylor y John M. Kelly. "Challenges in Chagas Disease Drug Development". Molecules 25, n.º 12 (17 de junio de 2020): 2799. http://dx.doi.org/10.3390/molecules25122799.
Texto completoChen, Xin, Giuseppe Gumina y Kristopher G. Virga. "Recent Advances in Drug Repurposing for Parkinson’s Disease". Current Medicinal Chemistry 26, n.º 28 (25 de octubre de 2019): 5340–62. http://dx.doi.org/10.2174/0929867325666180719144850.
Texto completoZeng, Xiangxiang, Siyi Zhu, Xiangrong Liu, Yadi Zhou, Ruth Nussinov y Feixiong Cheng. "deepDR: a network-based deep learning approach to in silico drug repositioning". Bioinformatics 35, n.º 24 (22 de mayo de 2019): 5191–98. http://dx.doi.org/10.1093/bioinformatics/btz418.
Texto completoGaikwad, Nikita Maruti, Pravin Digambar Chaudhari, Karimunnisa Sameer Shaikh, Somdatta Yashwant Chaudhari, Rasha Mohammed Saleem, Mohammad Algahtani, Ahmed E. Altyar, Ghadeer M. Albadrani, Mohamed Kamel y Mohamed M. Abdel-Daim. "Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis". PLOS ONE 18, n.º 8 (16 de agosto de 2023): e0287198. http://dx.doi.org/10.1371/journal.pone.0287198.
Texto completoLochab, Amit, Rakhi Thareja, Sangeeta D. Gadre y Reena Saxena. "Potential Protein and Enzyme Targets for In‐silico Development and Repurposing of Drug Against Coronaviruses". ChemistrySelect 6, n.º 46 (8 de diciembre de 2021): 13363–81. http://dx.doi.org/10.1002/slct.202103350.
Texto completoBruno, Agostino, Gabriele Costantino, Luca Sartori y Marco Radi. "The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization". Current Medicinal Chemistry 26, n.º 21 (19 de septiembre de 2019): 3838–73. http://dx.doi.org/10.2174/0929867324666171107101035.
Texto completoChoudhary, Gajendra, Niharika Dadoo Dadoo, Manisha Prajapat y Bikash Medhi. "In-silico Pharmacology for Evidence-Based and Precision Medicine". International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) 16, n.º 3 (4 de agosto de 2023): 6489–90. http://dx.doi.org/10.37285/ijpsn.2023.16.3.1.
Texto completoBintener, Tamara, Maria Pires Pacheco y Thomas Sauter. "Towards the routine use of in silico screenings for drug discovery using metabolic modelling". Biochemical Society Transactions 48, n.º 3 (5 de mayo de 2020): 955–69. http://dx.doi.org/10.1042/bst20190867.
Texto completoDe, Baishakhi, Koushik Bhandari, Francisco J. B. Mendonça, Marcus T. Scotti y Luciana Scotti. "Computational Studies in Drug Design Against Cancer". Anti-Cancer Agents in Medicinal Chemistry 19, n.º 5 (27 de junio de 2019): 587–91. http://dx.doi.org/10.2174/1871520618666180911125700.
Texto completoDonadu, Matthew Gavino, Stefania Zanetti, Basem Battah, Helal F. Hetta, Danica Matusovits, Krisztina Kárpáti, Virág Finta et al. "Drug repurposing in the context of common bacterial pathogens". Acta Biologica Szegediensis 66, n.º 2 (27 de mayo de 2023): 140–49. http://dx.doi.org/10.14232/abs.2022.2.140-149.
Texto completoHudson, Matthew L. y Ram Samudrala. "Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform". Molecules 26, n.º 9 (28 de abril de 2021): 2581. http://dx.doi.org/10.3390/molecules26092581.
Texto completoLyne, Seán B. y Bakhtiar Yamini. "An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma". Cancers 13, n.º 8 (18 de abril de 2021): 1953. http://dx.doi.org/10.3390/cancers13081953.
Texto completoLin, Ko-Hong, Yejin Kim, Dung-Fang Lee y Xiaoqian Jiang. "Abstract LB169: Machine learning-based approach for glioblastoma drug repurposing on real-world patient data". Cancer Research 83, n.º 8_Supplement (14 de abril de 2023): LB169. http://dx.doi.org/10.1158/1538-7445.am2023-lb169.
Texto completoAherfi, Sarah, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola y Didier Raoult. "Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV". Future Microbiology 16, n.º 17 (noviembre de 2021): 1341–70. http://dx.doi.org/10.2217/fmb-2021-0019.
Texto completoVerma, Yogesh Kumar y Gurudutta Gangenahalli. "Data Mining for Drug Repurposing and New Targets Identification for Radioprotection". Defence Life Science Journal 2, n.º 3 (3 de agosto de 2017): 343. http://dx.doi.org/10.14429/dlsj.2.11671.
Texto completoBaby, Krishnaprasad, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak y Yogendra Nayak. "Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19". F1000Research 9 (23 de septiembre de 2020): 1166. http://dx.doi.org/10.12688/f1000research.26359.1.
Texto completoBernatchez, Jean A., Emily Chen, Mitchell V. Hull, Case W. McNamara, James H. McKerrow y Jair L. Siqueira-Neto. "High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi". Microorganisms 8, n.º 4 (26 de marzo de 2020): 472. http://dx.doi.org/10.3390/microorganisms8040472.
Texto completoAn, Gary, John Bartels y Yoram Vodovotz. "In silico augmentation of the drug development pipeline: examples from the study of acute inflammation". Drug Development Research 72, n.º 2 (16 de diciembre de 2010): 187–200. http://dx.doi.org/10.1002/ddr.20415.
Texto completoGalati, Salvatore, Miriana Di Stefano, Elisa Martinelli, Giulio Poli y Tiziano Tuccinardi. "Recent Advances in In Silico Target Fishing". Molecules 26, n.º 17 (24 de agosto de 2021): 5124. http://dx.doi.org/10.3390/molecules26175124.
Texto completoGaleana-Ascencio, Roberto A., Liliana Mendieta, Daniel I. Limon, Dino Gnecco, Joel L. Terán, María L. Orea y Alan Carrasco-Carballo. "β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease". International Journal of Molecular Sciences 24, n.º 9 (3 de mayo de 2023): 8164. http://dx.doi.org/10.3390/ijms24098164.
Texto completoRoundhill, Elizabeth Ann, Pan Pantziarka, Danielle E. Liddle, Lucy A. Shaw, Ghadeer Albadrani y Susan Ann Burchill. "Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates". Cancers 15, n.º 3 (26 de enero de 2023): 769. http://dx.doi.org/10.3390/cancers15030769.
Texto completoHajjo, Rima, Dima A. Sabbah, Osama H. Abusara, Reham Kharmah y Sanaa Bardaweel. "Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases". Viruses 15, n.º 2 (19 de febrero de 2023): 568. http://dx.doi.org/10.3390/v15020568.
Texto completoTugcu, Gulcin, Hande Sipahi y Ahmet Aydin. "Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents". Current Topics in Medicinal Chemistry 19, n.º 13 (27 de agosto de 2019): 1121–28. http://dx.doi.org/10.2174/1568026619666190618143552.
Texto completoTaibe, Noha Samir, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj y Mahmoud M. Elhefnawi. "Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment". Therapeutic Advances in Respiratory Disease 16 (enero de 2022): 175346662211327. http://dx.doi.org/10.1177/17534666221132736.
Texto completoSahoo, Alaka, Shivkanya Fuloria, Shasank S. Swain, Sujogya K. Panda, Mahendran Sekar, Vetriselvan Subramaniyan, Maitreyee Panda, Ajaya K. Jena, Kathiresan V. Sathasivam y Neeraj Kumar Fuloria. "Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach". Biomedicines 9, n.º 11 (20 de octubre de 2021): 1505. http://dx.doi.org/10.3390/biomedicines9111505.
Texto completoIbrahim, Kareem A., Omneya M. Helmy, Mona T. Kashef, Tharwat R. Elkhamissy y Mohammed A. Ramadan. "Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing". Pathogens 9, n.º 9 (12 de septiembre de 2020): 747. http://dx.doi.org/10.3390/pathogens9090747.
Texto completoMakhouri, Farahnaz R. y Jahan B. Ghasemi. "Combating Diseases with Computational Strategies Used for Drug Design and Discovery". Current Topics in Medicinal Chemistry 18, n.º 32 (5 de marzo de 2019): 2743–73. http://dx.doi.org/10.2174/1568026619666190121125106.
Texto completoVlainić, Josipa, Ozren Jović, Ivan Kosalec, Oliver Vugrek, Rozelindra Čož-Rakovac y Tomislav Šmuc. "In Vitro Confirmation of Siramesine as a Novel Antifungal Agent with In Silico Lead Proposals of Structurally Related Antifungals". Molecules 26, n.º 12 (8 de junio de 2021): 3504. http://dx.doi.org/10.3390/molecules26123504.
Texto completoLeelananda, Sumudu P. y Steffen Lindert. "Computational methods in drug discovery". Beilstein Journal of Organic Chemistry 12 (12 de diciembre de 2016): 2694–718. http://dx.doi.org/10.3762/bjoc.12.267.
Texto completoAndrei, Corina, Dragos Paul Mihai, Anca Zanfirescu, George Mihai Nitulescu y Simona Negres. "In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity". Pharmaceutics 14, n.º 12 (22 de noviembre de 2022): 2563. http://dx.doi.org/10.3390/pharmaceutics14122563.
Texto completoOzdemir, E. Sila, Hillary H. Le, Adem Yildirim y Srivathsan V. Ranganathan. "In Silico Screening and Testing of FDA-Approved Small Molecules to Block SARS-CoV-2 Entry to the Host Cell by Inhibiting Spike Protein Cleavage". Viruses 14, n.º 6 (24 de mayo de 2022): 1129. http://dx.doi.org/10.3390/v14061129.
Texto completoFrancis, Arul Prakash, Aftab Ahmad, Sri Durga Devi Nagarajan, Harish Sundar Yogeeswarakannan, Krishnaraj Sekar, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Asif Husain, Mohammed A. Bazuhair y Nandakumar Selvasudha. "Development of a Novel Red Clay-Based Drug Delivery Carrier to Improve the Therapeutic Efficacy of Acyclovir in the Treatment of Skin Cancer". Pharmaceutics 15, n.º 7 (10 de julio de 2023): 1919. http://dx.doi.org/10.3390/pharmaceutics15071919.
Texto completoChakravarty, Kaushik, Victor G. Antontsev, Maksim Khotimchenko, Nilesh Gupta, Aditya Jagarapu, Yogesh Bundey, Hypatia Hou, Neha Maharao y Jyotika Varshney. "Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform". Molecules 26, n.º 7 (29 de marzo de 2021): 1912. http://dx.doi.org/10.3390/molecules26071912.
Texto completo